| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Oligonucleotide |
| Molecule Category: | UNKNOWN |
| UNII: | S66Z65E10T |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| RNAI INHIBITOR | Complement C5 mRNA RNAi inhibitor | ClinicalTrials Other PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Glomerulonephritis, IGA | 2 | D005922 | ClinicalTrials |
| Atypical Hemolytic Uremic Syndrome | 2 | D065766 | ClinicalTrials |
| Hemoglobinuria, Paroxysmal | 2 | D006457 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297722 |
| FDA SRS | S66Z65E10T |
CONTENTS